Citation: | SUN Bo, ZHOU Fang, XUE Fumin, LI Xiaoqin. Expression and correlation analysis of serum soluble myeloidcell trigger receptor 1, interleukin-21, 25 (OH) vitamin D in children with inflammatory bowel disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(14): 105-108, 113. DOI: 10.7619/jcmp.20230984 |
To investigate the expression of serum soluble myeloid cell trigger receptor 1(sTREM-1), interleukin-21(IL-21), 25 (OH) vitamin D[25(OH)D]in children with inflammatory bowel disease and their relations.
A total of 107 children with inflammatory bowel disease were selected as research objects and included in observation group. At the same time, 53 healthy people were selected as control group. The patients in the observation group were divided into active stage group (n=54) and remission stage group (n=53) according to disease activity. The expression of sTREM-1, IL-21, 25(OH)D were compared between the observation group and the control group and between active stage group and remission stage group. Kendall's tau-b method was used to analyze the correlations of sTREM-1, IL-21 and 25(OH)D with inflammatory bowel disease activity. Receiver operating characteristic (ROC) curve model was used to analyze the area under the curve (AUC) value, sensitivity and specificity of sTREM-1, IL-21 and 25(OH)D in the diagnosis and prediction of inflammatory bowel disease (IBD).
The serum levels of sTREM-1 and IL-21 in the observation group were higher than those in the control group, but level was lower than that in the control group (P < 0.05). The serum levels of sTREM-1 and IL-21 levels in the active stage group were higher than those in the remission stage group, but 25(OH)D level was lower than that in the remission stage group (P < 0.05). Kendall′s tau-b correlation analysis showed that sTREM-1 and IL-21 were positively correlated with inflammatory bowel disease activity (r=0.460, 0.484; P < 0.05). 25(OH)D was negatively correlated with inflammatory bowel disease activity (r=-0.434, P < 0.05). ROC curve analysis showed that the AUC values of sTREM-1, IL-21, 25(OH)Dand their combination in the diagnosis of inflammatory bowel disease were 0.791, 0.852, 0.808, 0.862, respectively(P < 0.05), and the sensitivities were 74.80%, 81.30%, 75.50% and 81.30%, respectively. The specificities were 75.50%, 75.50%, 81.30% and 79.20%, respectively. The AUC values of sTREM-1, IL-21, 25(OH)D and their combination in predicting the active phase of inflammatory bowel disease were 0.821, 0.840, 0.799, 0.840, respectively (P < 0.05), the sensitivities were 79.60%, 75.90%, 77.40% and 87.00%, respectively, and the specificities were 79.20%, 75.50%, 83.30% and 79.20%, respectively.
Serum levels of sTREM-1, IL-21, 25(OH)D are closely related to the occurrence and development of inflammatory bowel disease. Dynamic monitoring of their levels is helpful to provide an important reference for clinical diagnosis of inflammatory bowel disease and evaluation of disease progression in children.
[1] |
吴榕, 王英德, 毛靖伟. 炎症性肠病并发常见机会性病毒感染患者的临床特点及处理策略[J]. 中国全科医学, 2021, 24(15): 1853-1860. doi: 10.12114/j.issn.1007-9572.2021.00.407
|
[2] |
邢瑞欣, 王洪乾, 章文慧, 等. 检测炎症性肠病患者血清铜/锌比值的临床意义[J]. 中华消化杂志, 2021, 41(10): 665-670. doi: 10.3760/cma.j.cn311367-20210107-00017
|
[3] |
中华医学会儿科学会消化学组儿童炎症性肠病协作组, 陈洁, 许春娣, 等. 儿童炎症性肠病诊断规范共识意见[J]. 中国实用儿科杂志, 2010, 25(4): 263-265. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201004013.htm
|
[4] |
中华医学会儿科学分会消化学组, 中华医学会儿科学分会临床营养学组. 儿童炎症性肠病诊断和治疗专家共识[J]. 中华儿科杂志, 2019, 57(7): 501-507.
|
[5] |
杨宏, 张铭光, 王治东, 等. 血清免疫炎症相关蛋白复合物、25-羟维生素D、脂肪细胞因子与炎症性肠病患者疾病活动性和肠道菌群的相关性研究[J]. 现代生物医学进展, 2022, 22(14): 2653-2657. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202214010.htm
|
[6] |
王洪, 马燕春. NLRP1、NLRP3炎性体信号通路在儿童炎症性肠病免疫机制中的作用研究[J]. 中国当代儿科杂志, 2020, 22(8): 854-859. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ202008009.htm
|
[7] |
方莹, 孙丽娜, 韩亚楠, 等. 炎症性肠病患儿血清Th17相关细胞因子表达及其意义[J]. 中国实用儿科杂志, 2020, 35(2): 137-141. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK202002014.htm
|
[8] |
魏娜, 郑斌, 刘茂柏. 英夫利西单抗失应答的被动治疗药物监测在炎症性肠病治疗中的药物经济学系统评价[J]. 中国医院药学杂志, 2021, 41(3): 251-256. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ202103005.htm
|
[9] |
杨会云, 吴成, 龙云, 等. 炎症性肠病患儿血浆25(OH)D、Hepc、Hb水平变化及意义[J]. 山东医药, 2020, 60(19): 13-16. doi: 10.3969/j.issn.1002-266X.2020.19.004
|
[10] |
辜德明, 周家仍, 罗旋, 等. 炎症性肠病患儿结肠镜检查表现及血清可溶性髓系细胞触发性受体1水平变化[J]. 中国临床医生杂志, 2021, 49(7): 865-868. doi: 10.3969/j.issn.2095-8552.2021.07.034
|
[11] |
曾丽娟, 姚友东. 血必净辅助治疗对重症肺炎患儿Th17/Treg、血清sTREM-1水平的影响及其分子机制研究[J]. 免疫学杂志, 2021, 37(8): 731-736. https://www.cnki.com.cn/Article/CJFDTOTAL-MYXZ202108017.htm
|
[12] |
龚英峰. 感染性肺炎新生儿血清sICAM1、sTREM-1变化及与免疫和炎症反应的相关性研究[J]. 昆明医科大学学报, 2020, 41(3): 121-127. doi: 10.3969/j.issn.1003-4706.2020.03.024
|
[13] |
UMAR N, KING D, CHANDAN J S, et al. The association between inflammatory bowel disease and mental ill health: a retrospective cohort study using data from UK primary care[J]. Aliment Pharmacol Ther, 2022, 56(5): 814-822. doi: 10.1111/apt.17110
|
[14] |
张文婷, 赵红梅, 罗艳红, 等. 儿童炎症性肠病艰难梭菌感染及其易感因素分析[J]. 中国当代儿科杂志, 2021, 23(7): 718-723. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ202107010.htm
|
[15] |
杨文宏, 孙惠芳, 杨洁. miR-125b和miR-335在炎症性肠病患者外周血和肠黏膜中的表达研究[J]. 重庆医学, 2021, 50(5): 800-805. doi: 10.3969/j.issn.1671-8348.2021.05.019
|
[16] |
CHOE Y J, HAN K, SHIM J O. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study[J]. Aliment Pharmacol Ther, 2022, 56(6): 980-988. doi: 10.1111/apt.17125
|
[17] |
许建勇, 王丽, 时艳, 等. 巨细胞病毒感染与炎症性肠病患者糖皮质激素剂量、CD4+T淋巴细胞数量的相关性[J]. 中华医院感染学杂志, 2022, 32(9): 1315-1318. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202209009.htm
|